Inno, A., Bogina, G., Settanni, G., Salgarello, M., Foti, G., Pomari, C., Picece, V. and Gori, S. 2023. First-line tepotinib for a very elderly patient with metastatic NSCLC harboring MET exon 14 skipping mutation and high PD-L1 expression. Drug Target Insights. 17, 1 (Oct. 2023), 110–113. DOI:https://doi.org/10.33393/dti.2023.2626.